J L Michaux
Overview
Explore the profile of J L Michaux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
192
Citations
923
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Busschots A, Mecucci C, Stul M, Vandenberghe E, Michaux J, Noel H, et al.
Leuk Lymphoma
. 2016 Jul;
5(4):281-6.
PMID: 27467851
A translocation (14;19)(q32;q13.1) was found in a 31 year old man with a large cell lymphoma which had evolved from chronic lymphocytic leukaemia (CLL). Molecular analysis showed a monoclonal proliferation...
2.
Boonen A, Lefebvre C, Lambert M, Fcrrant A, Michaux J, Coche E
Acta Clin Belg
. 2016 May;
47(6):397-400.
PMID: 27238402
We report 2 cases of hypothyroidism in whom the associated haematological disturbances (macrocytic anaemia in both cases, mild leukopenia and thrombo-penia in one patient) failed to be corrected by thyroid...
3.
Van Den Berghe E, Mecucci C, Rodhain J, Michaux J, de Bruyere M, Van Den Berghe H
Leuk Lymphoma
. 2011 Jan;
5(2-3):201-5.
PMID: 21269082
We report three cases of small B cell non Hodgkins lymphoma, two with plasmacytoid differentiation, presenting with a similar clinical picture and identical immunophenotype, who cytogenetically had breakpoints involving band...
4.
Michaux J
Bull Mem Acad R Med Belg
. 2006 Dec;
161(3-4):171-80.
PMID: 17172225
No abstract available.
5.
Van Den Neste E, Louviaux I, Michaux J, Delannoy A, Michaux L, Sonet A, et al.
Leukemia
. 2000 Jun;
14(6):1136-42.
PMID: 10865980
Because of their substantial in vitro synergy, we conducted a dose-escalation study of cyclophosphamide (CP) added to 2-chloro-2'-deoxyadenosine (CdA) in patients with previously treated chronic lymphocytic leukemia and non-Hodgkin's lymphoma....
6.
Goasguen J, Zandecki M, Mathiot C, Scheiff J, Bizet M, Ly-Sunnaram B, et al.
Leuk Res
. 1999 Dec;
23(12):1133-40.
PMID: 10613359
The relationship between plasmablastic cells and outcome in multiple myeloma (MM) has been established for nearly 15 years. But the assessment of these cells is not easy to perform and...
7.
Lecouvet F, Malghem J, Michaux L, Maldague B, Ferrant A, Michaux J, et al.
Br J Haematol
. 1999 Aug;
106(1):35-9.
PMID: 10444160
In an attempt to compare the sensitivity of bone radiographs and bone marrow magnetic resonance (MR) imaging for bone lesion detection in patients with stage III multiple myeloma (MM) and...
8.
Van Den Neste E, Louviaux I, Michaux J, Delannoy A, Michaux L, Hagemeijer A, et al.
Br J Haematol
. 1999 May;
105(1):268-70.
PMID: 10233391
A few cases of secondary neoplasms occurring after treatment with 2-chloro-2'-deoxyadenosine (2CdA) have been reported, mostly in patients previously exposed to other anti-cancer drugs including alkylating agents (AA). Here we...
9.
Delannoy A, Van Den Neste E, Michaux J, Bosly A, Ferrant A
Br J Haematol
. 1999 Apr;
104(4):933-4.
PMID: 10192467
No abstract available.
10.
Lecouvet F, Vande Berg B, Michaux L, Malghem J, Maldague B, Jamart J, et al.
Radiology
. 1998 Dec;
209(3):653-60.
PMID: 9844655
Purpose: To determine the clinical and prognostic value of spinal bone marrow magnetic resonance (MR) imaging in stage III multiple myeloma. Materials And Methods: In 80 patients with untreated, newly...